Biohaven Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.39

-0.35 (-4.00%)

As of Mar 24, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 75%

Hold 6 25%

Sell 0 0%

Price Target

Analyst Price Target +258.3% upside

Low Target $17.22

Average Target $30.06

High Target $35.82

Current Price $8.39

Current
$8.39

Target
$30.06

$17.22 $30.06 avg $35.82

Scenario Analysis

Bear Case

$17.22

105.2%

Low target

Base Case

$30.06

+258.3%

Avg target

Bull Case

$35.82

+326.9%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$40.82

-79.4% from high

52-Week Low

$7.48

+12.2% from low

Target vs 52W High

$30.06

-26.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%